ČEŠKOVÁ, Eva. The need to improve current psychopharmacotherapy before developing new drugs. EXPERT OPINION ON PHARMACOTHERAPY. LONDON: INFORMA HEALTHCARE, 2014, vol. 15, No 14, p. 1969-1973. ISSN 1465-6566. Available from: https://dx.doi.org/10.1517/14656566.2014.941806.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name The need to improve current psychopharmacotherapy before developing new drugs
Authors ČEŠKOVÁ, Eva (203 Czech Republic, guarantor, belonging to the institution).
Edition EXPERT OPINION ON PHARMACOTHERAPY, LONDON, INFORMA HEALTHCARE, 2014, 1465-6566.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30000 3. Medical and Health Sciences
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 3.534
RIV identification code RIV/00216224:14740/14:00082092
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1517/14656566.2014.941806
UT WoS 000341993800001
Keywords in English genotyping; non- adherence; phenotyping; psychopharmacotherapy; therapeutic drug monitoring; treatment optimization
Tags poznámka, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Eva Špillingová, učo 110713. Changed: 29/4/2016 12:33.
Abstract
CNS research has become unprofitable, and several pharmaceutical companies have reduced financial support for developing new CNS drugs. Until the situation can be changed, it is our duty to optimize the usage of the currently available psychoactive drugs. Several tools for optimizing pharmacotherapy are available, such as therapeutic drug monitoring and genotyping and phenotyping CYP enzymes. Further medical treatment and healthcare provision for patients with severe mental disorders should be improved. Knowledge of psychopharmacotherapy influences the choices of medication and outcomes; therefore, future psychiatrists should have a greater knowledge of pharmacodynamics, pharmacokinetics and pharmacogenetics.
Links
ED1.1.00/02.0068, research and development projectName: CEITEC - central european institute of technology
PrintDisplayed: 24/8/2024 19:14